These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

100 related items for PubMed ID: 12153400

  • 1. The type 2 vascular endothelial growth factor receptor recruits insulin receptor substrate-1 in its signalling pathway.
    Senthil D, Ghosh Choudhury G, Bhandari BK, Kasinath BS.
    Biochem J; 2002 Nov 15; 368(Pt 1):49-56. PubMed ID: 12153400
    [Abstract] [Full Text] [Related]

  • 2. VEGF regulation of endothelial nitric oxide synthase in glomerular endothelial cells.
    Feliers D, Chen X, Akis N, Choudhury GG, Madaio M, Kasinath BS.
    Kidney Int; 2005 Oct 15; 68(4):1648-59. PubMed ID: 16164642
    [Abstract] [Full Text] [Related]

  • 3. Angiotensin II impairs the insulin signaling pathway promoting production of nitric oxide by inducing phosphorylation of insulin receptor substrate-1 on Ser312 and Ser616 in human umbilical vein endothelial cells.
    Andreozzi F, Laratta E, Sciacqua A, Perticone F, Sesti G.
    Circ Res; 2004 May 14; 94(9):1211-8. PubMed ID: 15044323
    [Abstract] [Full Text] [Related]

  • 4. Characterization of multiple signaling pathways of insulin in the regulation of vascular endothelial growth factor expression in vascular cells and angiogenesis.
    Jiang ZY, He Z, King BL, Kuroki T, Opland DM, Suzuma K, Suzuma I, Ueki K, Kulkarni RN, Kahn CR, King GL.
    J Biol Chem; 2003 Aug 22; 278(34):31964-71. PubMed ID: 12775712
    [Abstract] [Full Text] [Related]

  • 5. Interferon-dependent activation of the serine kinase PI 3'-kinase requires engagement of the IRS pathway but not the Stat pathway.
    Uddin S, Majchrzak B, Wang PC, Modi S, Khan MK, Fish EN, Platanias LC.
    Biochem Biophys Res Commun; 2000 Apr 02; 270(1):158-62. PubMed ID: 10733921
    [Abstract] [Full Text] [Related]

  • 6. Extracellular matrix induced by TGFbeta impairs insulin signal transduction in 3T3-L1 preadipose cells.
    Gagnon AM, Chabot J, Pardasani D, Sorisky A.
    J Cell Physiol; 1998 Jun 02; 175(3):370-8. PubMed ID: 9572482
    [Abstract] [Full Text] [Related]

  • 7. A unique signal transduction from FLT tyrosine kinase, a receptor for vascular endothelial growth factor VEGF.
    Seetharam L, Gotoh N, Maru Y, Neufeld G, Yamaguchi S, Shibuya M.
    Oncogene; 1995 Jan 05; 10(1):135-47. PubMed ID: 7824266
    [Abstract] [Full Text] [Related]

  • 8. Vascular endothelial growth factor induces protein synthesis in renal epithelial cells: a potential role in diabetic nephropathy.
    Senthil D, Choudhury GG, McLaurin C, Kasinath BS.
    Kidney Int; 2003 Aug 05; 64(2):468-79. PubMed ID: 12846742
    [Abstract] [Full Text] [Related]

  • 9. Essential role of insulin receptor substrate 1 in differentiation of brown adipocytes.
    Fasshauer M, Klein J, Kriauciunas KM, Ueki K, Benito M, Kahn CR.
    Mol Cell Biol; 2001 Jan 05; 21(1):319-29. PubMed ID: 11113206
    [Abstract] [Full Text] [Related]

  • 10. The p85 regulatory subunit of phosphoinositide 3-kinase down-regulates IRS-1 signaling via the formation of a sequestration complex.
    Luo J, Field SJ, Lee JY, Engelman JA, Cantley LC.
    J Cell Biol; 2005 Aug 01; 170(3):455-64. PubMed ID: 16043515
    [Abstract] [Full Text] [Related]

  • 11. Insulin receptor substrate (IRS) proteins IRS-1 and IRS-2 differential signaling in the insulin/insulin-like growth factor-I pathways in fetal brown adipocytes.
    Valverde AM, Lorenzo M, Pons S, White MF, Benito M.
    Mol Endocrinol; 1998 May 01; 12(5):688-97. PubMed ID: 9605931
    [Abstract] [Full Text] [Related]

  • 12. Interaction of insulin receptor substrate-1 (IRS-1) with phosphatidylinositol 3-kinase: effect of substitution of serine for alanine in potential IRS-1 serine phosphorylation sites.
    Delahaye L, Mothe-Satney I, Myers MG, White MF, Van Obberghen E.
    Endocrinology; 1998 Dec 01; 139(12):4911-9. PubMed ID: 9832428
    [Abstract] [Full Text] [Related]

  • 13. Muscarinic-receptor-mediated inhibition of insulin-like growth factor-1 receptor-stimulated phosphoinositide 3-kinase signalling in 1321N1 astrocytoma cells.
    Batty IH, Fleming IN, Downes CP.
    Biochem J; 2004 May 01; 379(Pt 3):641-51. PubMed ID: 14769130
    [Abstract] [Full Text] [Related]

  • 14. Characterization of selective resistance to insulin signaling in the vasculature of obese Zucker (fa/fa) rats.
    Jiang ZY, Lin YW, Clemont A, Feener EP, Hein KD, Igarashi M, Yamauchi T, White MF, King GL.
    J Clin Invest; 1999 Aug 01; 104(4):447-57. PubMed ID: 10449437
    [Abstract] [Full Text] [Related]

  • 15. Insulin receptor substrate 3 (IRS-3) and IRS-4 impair IRS-1- and IRS-2-mediated signaling.
    Tsuruzoe K, Emkey R, Kriauciunas KM, Ueki K, Kahn CR.
    Mol Cell Biol; 2001 Jan 01; 21(1):26-38. PubMed ID: 11113178
    [Abstract] [Full Text] [Related]

  • 16. Regulation of insulin receptor, insulin receptor substrate-1 and phosphatidylinositol 3-kinase in 3T3-F442A adipocytes. Effects of differentiation, insulin, and dexamethasone.
    Saad MJ, Folli F, Araki E, Hashimoto N, Csermely P, Kahn CR.
    Mol Endocrinol; 1994 May 01; 8(5):545-57. PubMed ID: 7520127
    [Abstract] [Full Text] [Related]

  • 17. Inhibition of insulin-like growth factor signaling pathways in mammary gland by pure antiestrogen ICI 182,780.
    Chan TW, Pollak M, Huynh H.
    Clin Cancer Res; 2001 Aug 01; 7(8):2545-54. PubMed ID: 11489838
    [Abstract] [Full Text] [Related]

  • 18. Tyrosine residues in the C-terminal domain of the insulin-like growth factor-I receptor mediate mitogenic and tumorigenic signals.
    Esposito DL, Blakesley VA, Koval AP, Scrimgeour AG, LeRoith D.
    Endocrinology; 1997 Jul 01; 138(7):2979-88. PubMed ID: 9202243
    [Abstract] [Full Text] [Related]

  • 19. VEGF-induced activation of phosphoinositide 3-kinase is dependent on focal adhesion kinase.
    Qi JH, Claesson-Welsh L.
    Exp Cell Res; 2001 Feb 01; 263(1):173-82. PubMed ID: 11161716
    [Abstract] [Full Text] [Related]

  • 20. Autophosphorylation of KDR in the kinase domain is required for maximal VEGF-stimulated kinase activity and receptor internalization.
    Dougher M, Terman BI.
    Oncogene; 1999 Feb 25; 18(8):1619-27. PubMed ID: 10102632
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.